SMTL ID : 5ohj.2 (1 other biounit)

Human phosphodiesterase 4B catalytic domain in complex with a pyrrolidinyl inhibitor.

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.60 Å

Oligo State

monomer

Ligands

1 x ZN: ZINC ION(Non-covalent)

ZN.1: 5 residues within 4Å: Chain A: H.166, H.202, D.203, D.320 Ligands: MG.2 6 PLIP interactions: 4 interactions with chain A, 2 Ligand-Water interactions Metal complexes: A:H.166, A:H.202, A:D.203, A:D.320, H2O.1, H2O.2

1 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 2 residues within 4Å: Chain A: D.203 Ligands: ZN.1 6 PLIP interactions: 1 interactions with chain A, 5 Ligand-Water interactions Metal complexes: A:D.203, H2O.2, H2O.2, H2O.2, H2O.2, H2O.2

1 x 9VE: [(1~{S})-2-[3,5-bis(chloranyl)-1-oxidanyl-pyridin-1-ium-4-yl]-1-[4-[bis(fluoranyl)methoxy]-3-(cyclopropylmethoxy)phenyl]ethyl] (2~{S})-1-[3-(dimethylcarbamoyl)phenyl]sulfonylpyrrolidine-2-carboxylate(Non-covalent)

9VE.3: 22 residues within 4Å: Chain A: Y.161, S.210, E.232, T.273, M.275, D.320, L.321, N.323, P.324, Y.331, W.334, T.335, I.338, F.342, Q.345, P.358, M.359, C.360, S.370, Q.371, F.374, I.378 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:F.342, A:F.374, A:I.378 Hydrogen bonds: A:E.232, A:M.275, A:Q.371 pi-Stacking: A:F.374

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Carzaniga, L. et al., Discovery and Optimization of Thiazolidinyl and Pyrrolidinyl Derivatives as Inhaled PDE4 Inhibitors for Respiratory Diseases. J. Med. Chem. (2017)

Release Date

2017-12-13

Peptides

cAMP-specific 3',5'-cyclic phosphodiesterase 4B: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

cAMP-specific 3',5'-cyclic phosphodiesterase 4B

Related Entries With Identical Sequence